Prostate Cancer and Androgenic Alopecia: The Role of Finasteride as a Dual Agent

    January 2021 in “ HAMDAN MEDICAL JOURNAL ”
    Jabir Jassam
    Studysummary This study reports that finasteride can effectively treat androgenic alopecia and may reduce prostate cancer risk by 25% in men with risk factors.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on hamdanjournal.org →
    Discuss this study in the Community →

    Related research 12

    1. The Clinical Applications of Five-Alpha Reductase Inhibitors Canadian Journal of Urology · 2021
    2. Current Pharmacological Treatment for Male LUTS Due to BPH: Dutasteride or Finasteride? Current Drug Targets · 2015
    3. Long-Term Use of 5α-Reductase Inhibitors and the Risk of Male Breast Cancer Cancer Causes & Control · 2014
    4. Prostate Cancer and Androgenic Alopecia Expert Review of Endocrinology & Metabolism · 2012
    5. Regarding Prostate-Specific Antigen: Let's Not Shoot the Messenger QJM · 2011
    6. Therapeutic Hotline: Treatment of Androgenic Alopecia with Finasteride May Result in High-Grade Prostate Cancer in Patients: Fact or Fiction? Dermatologic Therapy · 2010
    7. Finasteride: Its Impact on Sexual Function and Prostate Cancer Journal of Cutaneous and Aesthetic Surgery · 2009
    8. Finasteride for Prostatic Disease: An Updated and Comprehensive Review Expert opinion on drug metabolism & toxicology · 2008
    9. Role of 5 Alpha-Reductase Inhibitors in the Management of Prostate Cancer Clinical interventions in aging · 2006
    10. 5α-Reductase Inhibitors and Chemoprevention: The PCPT and Beyond European Urology Supplements · 2006
    11. Long-Term Experience With 5-Alpha-Reductase Inhibitors PubMed · 2003
    12. Finasteride Drugs · 1993